home.aspx
 
EVENTS

Medicinal and Pharmaceutical Chemistry
MEDICINAL AND PHARMACEUTICAL CHEMISTRY
December 16-17, 2019
Medicinal Chemistry is the science of design and chemical synthesis focusing mainly on small organic molecules and their development of pharmaceutical agents, or bio-active molecules (drugs). Pharmaceutical Chemistry is the same plus the science of pharmaceutical and biomedical analysis to the synth...

Drug Formulation & Analytical Techniques
DRUG FORMULATION & ANALYTICAL TECHNIQUES
December 16-17, 2019
Pharmaceutical formulation in pharmaceutics is the process in which various chemical substances including the vigorous drug are joined to produce a final medicinal product. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally...

BIAL

Founded in 1924, BIAL’s mission is to discover, develop and provide new therapeutic solutions within the area of Health. Today, BIAL is an innovative international pharmaceutical company with products available in more than 55 countries. The company is committed to making a contribution to improve human health and quality of life for people from all over the world. “Caring for your Health” is the Group’s motto, and strategic areas are Innovation, Internationalization and Quality.

RELATED NEWS


With big pharma still abandoning R and D into antibiotics and resistant infections on the rise, the UK has launched a new payment system that it hopes will incentivise the development of new drugs. A new subscription approach will see companies paid upfront for access to new antibiotics based on their value to the NHS, rather than the volume of medicines sold, according to Health Secretary Matt Hancock. The idea is that this will give companies who develop innovative antimicrobials a greater ret...

READ MORE

Two injected drugs manufactured by an Indian company with a history of sterility problems are being recalled because of microbial contamination. The drugs were both manufactured by Emcure Pharmaceuticals but are distributed in the U.S. by Heritage Pharmaceuticals.East Brunswick, New Jersey-based Heritage Saturday issued the voluntary recall to the consumer level for sublots of infection fighter amikacin sulfate injection and schizophrenia drug prochlorperazine edisylate after microbial growth wa...

READ MORE

Nearly 20 years after the attacks of September 11, 2001, Khalid El-Salem, MD still remembers the efforts Donald Sanders, MD, took to make him feel welcome and at home when he was a neuromuscular/EMG fellow at Duke during that time. Now back in his native Jordan, El-Salem is balancing his roles as a clinical neurologist with his leadership and administrative responsibilities as vice president for the country’s leading university. For our Alumni Spotlight interview, El-Salem talks about his ...
NEUROLOGY
READ MORE

The UK government has published a new five-year plan aimed at tackling antimicrobial resistance (AMR), including a new NHS reimbursement scheme backed by NICE to encourage pharma to develop new antibiotics. Health secretary Matt Hancock announced the new plan at the World Economic Forum in Davos, in order to raise awareness among global leaders about the scale of the problem. Over the last few decades, development of new antibiotics has almost ground to a halt as big pharma does not think it is ...

READ MORE

Novo Holdings’ REPAIR Impact Fund, which helps fund companies tackling antimicrobial resistance (AMR), has announced three new investments. The first beneficiary is AstraZeneca spin-off Entasis Therapeutics, whose programmes include a new class of non-β-lactam PBP inhibitors (NBP) targeting multi-resistant Pseudomonas aeruginosa infections. The REPAIR Fund participated in the $75 million NASDAQ listing in September 2018 by investing $10 million. A report published last year named Enta...

READ MORE

AmpliPhi Biosciences  Corporation (“AmpliPhi”) (NYSE American: APHB), a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, and C3J Therapeutics, Inc. (“C3J”), a private clinical stage biotechnology company focused on the development of novel targeted antimicrobials, today announced that the companies have entered into a definitive agreement under which a wholly owned su...

READ MORE

Spark Therapeutics’ gene therapy for a rare inherited sight disorder, Luxturna has been approved in Europe, but there was still no word on price from marketing partner Novartis. The European Commission granted a marketing authorization for Luxturna as a one-time gene therapy for adult and paediatric patients with vision loss due to inherited dystrophy caused by confirmed biallelic RPE65 mutations. Patients must also have sufficient viable retinal cells to be eligible. Novartis will market ...

READ MORE

Inflammation in the body is an important mechanism that helps to heal. But, as is well known, it can also create problems by aggravating injuries and intensifying various medical conditions. Researchers at the Wyss Institute at Harvard University have been working on getting a handle on the process of inflammation so as to be able to better guide how it heals the body.
The team has focused on being able to switch macrophages, the white blood cells of the immune system found at sites of in...

WYSS INSTITUTE
READ MORE

Uncultured microbes those whose characteristics have never been described because they have not yet been grown in a lab culture could be dominating nearly all the environments on Earth except for the human body, according to a new study published in systems. The research was led by Karen Lloyd, associate professor in the University of Tennessee, Knoxville's Department of Microbiology. Lloyd's study is the first time the population of uncultured microbes has been estimated.
Scienti...

UNIVERSITY OF TENNESSEE AT KNOXVILLE
READ MORE

New research showing that the first bacteria introduced into the gut have a lasting impact may one day allow scientists to adjust microbiomes the one-of-a-kind microbial communities that live in our gastrointestinal tracts to help ward off serious chronic diseases. Findings by U of A microbial ecologist Jens Walter and his colleagues suggest differences in our microbial makeup likely depend on when we acquire our first microorganisms after birth and the order they arrive in our gut has a lasting...

READ MORE

EVENTS

International Conference on Metabolic Diseases and Liver Cancer
INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER
December 16-17, 2019
“INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER ’’ is organized in order to bring light and anticipate to the dark sides of human liver cancer and irregular human metabolic diseases which are prevailing worldwide. This conference is effective on all sides as it giv...

Medicinal and Pharmaceutical Chemistry
MEDICINAL AND PHARMACEUTICAL CHEMISTRY
December 16-17, 2019
Medicinal Chemistry is the science of design and chemical synthesis focusing mainly on small organic molecules and their development of pharmaceutical agents, or bio-active molecules (drugs). Pharmaceutical Chemistry is the same plus the science of pharmaceutical and biomedical analysis to the synth...